Enhance MD vs Ro.co: Semaglutide Compounds vs Wegovy Pill
Quick verdict: Enhance MD is best for lowest first-month compound pricing and flat-rate dosing; Ro.co is best for access to the FDA-approved Wegovy pill and an oral option. This article compares Enhance MD vs Ro.co across pricing, medication type and regulatory status, dose pricing structure, and platform focus so you can choose based on what matters most.
Start Enhance MD semaglutide from $49
Direct comparison summary: core differences
Enhance MD offers compounded semaglutide from $49 first month and compounded tirzepatide from $99 first month with flat-rate pricing that stays the same at every dose. Ro.co advertises getting started online for just $39 and provides access to the Wegovy pill, an FDA-approved oral GLP-1 finished medication. Treatment at both platforms is available only when a licensed clinician determines it is medically appropriate. Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Five-point comparison table
| Criteria | Enhance MD | Ro.co |
|---|---|---|
| Starting price | Semaglutide starting at $49 first month; tirzepatide from $99 first month | Get started online for just $39 |
| Medication type | Compounded semaglutide and tirzepatide (clinician-directed) | Wegovy pill, FDA-approved oral GLP-1 finished medication |
| Dose pricing structure | Flat-rate pricing: same price at every dose, no escalation | Ongoing branded medication pricing varies by plan; pricing disclosed before consultation |
| Regulatory status | Compounded medications not FDA-approved and not reviewed by FDA for safety, effectiveness or quality | Offers FDA-approved finished product (Wegovy pill) |
| Best for | Flat rate, same price at every dose; cost-sensitive early months | Injection-averse patients; preference for FDA-approved oral option |
Pricing and cost structure compared
Enhance MD highlights semaglutide from $49 and tirzepatide from $99 for the first month, and advertises ongoing flat-rate pricing so the price stays the same at every dose with no escalation during titration. Ro.co emphasizes a low entry point with “Get started online for just $39” and notes that branded FDA-approved medications generally carry higher ongoing costs and that pricing is disclosed before consultation. The sources state that Ro.co’s branded options can be significantly more expensive than compounded alternatives.
See Enhance MD pricing and flat-rate details
Medication options and regulatory clarity
Enhance MD provides compounded semaglutide and compounded tirzepatide on one platform and notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co is the only provider here captured that offers the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication on this list. That means Ro.co supplies a finished product with FDA approval, while Enhance MD supplies compounded alternatives subject to clinician review.
Explore Ro.co Wegovy pill option
Who each platform appears best for
Enhance MD is presented as strong for patients focused on initial affordability and predictable ongoing dose pricing: it has low first-month compound prices and flat-rate pricing that claims no fee escalation during titration. Ro.co is presented as the clear choice for injection-averse patients or those who prefer an FDA-approved oral medication and the regulatory clarity that comes with a branded finished product. Both require clinician determination that treatment is medically appropriate.
Other practical differences and disclosures
Enhance MD notes a clinician-directed review process and reports treating more than 10,000 patients. Ro.co emphasizes brand trust as an established full-service platform and that it discloses pricing before consultation. Both sources remind readers that compounded medications are not FDA-approved and not individually reviewed by the FDA.
Conclusion: choosing between Enhance MD vs Ro.co
Enhance MD vs Ro.co comes down to compound pricing and dosing predictability versus access to an FDA-approved oral GLP-1. Use the guidance below based only on the supplied facts.
- Choose Enhance MD if you prioritize the lowest first-month compound price and flat-rate, same-price-at-every-dose billing and want access to both semaglutide and tirzepatide as compounded options.
- Choose Ro.co if you prioritize the Wegovy pill, an FDA-approved oral GLP-1 finished medication, or if you are injection-averse and prefer regulatory clarity.